Lexington Partners L.P. Syndax Pharmaceuticals Inc Transaction History

Lexington Partners L.P.

  • $10.6 Million
  • Q3 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$15.23 - $22.47 $434,039 - $640,372
-28,499 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$13.87 - $19.8 $395,281 - $564,280
28,499 New
28,499 $545,000
Q1 2021

May 14, 2021
SELL
$19.28 - $24.59 $560,373 - $714,708
-29,065 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$15.1 - $26.44 $438,881 - $768,478
29,065 New
29,065 $646,000

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $940M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Lexington Partners L.P. Portfolio

Follow Lexington Partners L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lexington Partners L.P., based on Form 13F filings with the SEC.

News

Stay updated on Lexington Partners L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email